scispace - formally typeset
Search or ask a question
Institution

Wellcome Trust Sanger Institute

NonprofitCambridge, United Kingdom
About: Wellcome Trust Sanger Institute is a nonprofit organization based out in Cambridge, United Kingdom. It is known for research contribution in the topics: Population & Genome. The organization has 4009 authors who have published 9671 publications receiving 1224479 citations.


Papers
More filters
Journal ArticleDOI
Robert A. Scott1, Laura J. Scott2, Reedik Mägi3, Letizia Marullo4  +213 moreInstitutions (66)
01 Nov 2017-Diabetes
TL;DR: This article conducted a meta-analysis of genome-wide association data from 26,676 T2D case and 132,532 control subjects of European ancestry after imputation using the 1000 Genomes multiethnic reference panel.
Abstract: To characterize type 2 diabetes (T2D)-associated variation across the allele frequency spectrum, we conducted a meta-analysis of genome-wide association data from 26,676 T2D case and 132,532 control subjects of European ancestry after imputation using the 1000 Genomes multiethnic reference panel Promising association signals were followed up in additional data sets (of 14,545 or 7,397 T2D case and 38,994 or 71,604 control subjects) We identified 13 novel T2D-associated loci (P < 5 × 10-8), including variants near the GLP2R, GIP, and HLA-DQA1 genes Our analysis brought the total number of independent T2D associations to 128 distinct signals at 113 loci Despite substantially increased sample size and more complete coverage of low-frequency variation, all novel associations were driven by common single nucleotide variants Credible sets of potentially causal variants were generally larger than those based on imputation with earlier reference panels, consistent with resolution of causal signals to common risk haplotypes Stratification of T2D-associated loci based on T2D-related quantitative trait associations revealed tissue-specific enrichment of regulatory annotations in pancreatic islet enhancers for loci influencing insulin secretion and in adipocytes, monocytes, and hepatocytes for insulin action-associated loci These findings highlight the predominant role played by common variants of modest effect and the diversity of biological mechanisms influencing T2D pathophysiology

601 citations

Journal ArticleDOI
TL;DR: It is demonstrated that genes with a high predicted probability of exhibiting haploinsufficiency are enriched among genes implicated in human dominant diseases and among genes causing abnormal phenotypes in heterozygous knockout mice.
Abstract: Haploinsufficiency, wherein a single functional copy of a gene is insufficient to maintain normal function, is a major cause of dominant disease. Human disease studies have identified several hundred haploinsufficient (HI) genes. We have compiled a map of 1,079 haplosufficient (HS) genes by systematic identification of genes unambiguously and repeatedly compromised by copy number variation among 8,458 apparently healthy individuals and contrasted the genomic, evolutionary, functional, and network properties between these HS genes and known HI genes. We found that HI genes are typically longer and have more conserved coding sequences and promoters than HS genes. HI genes exhibit higher levels of expression during early development and greater tissue specificity. Moreover, within a probabilistic human functional interaction network HI genes have more interaction partners and greater network proximity to other known HI genes. We built a predictive model on the basis of these differences and annotated 12,443 genes with their predicted probability of being haploinsufficient. We validated these predictions of haploinsufficiency by demonstrating that genes with a high predicted probability of exhibiting haploinsufficiency are enriched among genes implicated in human dominant diseases and among genes causing abnormal phenotypes in heterozygous knockout mice. We have transformed these gene-based haploinsufficiency predictions into haploinsufficiency scores for genic deletions, which we demonstrate to better discriminate between pathogenic and benign deletions than consideration of the deletion size or numbers of genes deleted. These robust predictions of haploinsufficiency support clinical interpretation of novel loss-of-function variants and prioritization of variants and genes for follow-up studies.

601 citations

Journal ArticleDOI
Chris T. Amemiya1, Chris T. Amemiya2, Jessica Alföldi3, Alison P. Lee4, Shaohua Fan5, Hervé Philippe6, Iain MacCallum3, Ingo Braasch7, Tereza Manousaki5, Igor Schneider8, Nicolas Rohner9, Chris L. Organ10, Domitille Chalopin11, J. Joshua Smith12, Mark Robinson2, Rosemary A. Dorrington13, Marco Gerdol14, Bronwen Aken15, Maria Assunta Biscotti16, Marco Barucca16, Denis Baurain17, Aaron M. Berlin3, Gregory L. Blatch13, Gregory L. Blatch18, Francesco Buonocore, Thorsten Burmester19, Michael S. Campbell10, Adriana Canapa16, John P. Cannon20, Alan Christoffels21, Gianluca De Moro14, Adrienne L. Edkins13, Lin Fan3, Anna Maria Fausto, Nathalie Feiner5, Mariko Forconi16, Junaid Gamieldien21, Sante Gnerre3, Andreas Gnirke3, Jared V. Goldstone22, Wilfried Haerty23, Mark E. Hahn22, Uljana Hesse21, Steve Hoffmann24, Jeremy Johnson3, Sibel I. Karchner22, Shigehiro Kuraku5, Marcia Lara3, Joshua Z. Levin3, Gary W. Litman20, Evan Mauceli3, Evan Mauceli9, Tsutomu Miyake25, M. Gail Mueller26, David R. Nelson27, Anne Nitsche24, Ettore Olmo16, Tatsuya Ota28, Alberto Pallavicini14, Sumir Panji21, Barbara Picone21, Chris P. Ponting23, Sonja J. Prohaska24, Dariusz Przybylski3, Nil Ratan Saha2, Vydianathan Ravi4, Filipe J. Ribeiro3, Tatjana Sauka-Spengler23, Giuseppe Scapigliati, Stephen M. J. Searle15, Ted Sharpe3, Oleg Simakov5, Peter F. Stadler24, John J. Stegeman22, Kenta Sumiyama29, Diana Tabbaa3, Hakim Tafer24, Jason Turner-Maier3, Peter van Heusden21, Simon D. M. White15, Louise Williams3, Mark Yandell10, Henner Brinkmann6, Jean Nicolas Volff11, Clifford J. Tabin9, Neil H. Shubin30, Manfred Schartl31, David B. Jaffe3, John H. Postlethwait7, Byrappa Venkatesh4, Federica Di Palma3, Eric S. Lander3, Axel Meyer5, Kerstin Lindblad-Toh3, Kerstin Lindblad-Toh32 
18 Apr 2013-Nature
TL;DR: Through a phylogenomic analysis, it is concluded that the lungfish, and not the coelacanth, is the closest living relative of tetrapods.
Abstract: The discovery of a living coelacanth specimen in 1938 was remarkable, as this lineage of lobe-finned fish was thought to have become extinct 70 million years ago. The modern coelacanth looks remarkably similar to many of its ancient relatives, and its evolutionary proximity to our own fish ancestors provides a glimpse of the fish that first walked on land. Here we report the genome sequence of the African coelacanth, Latimeria chalumnae. Through a phylogenomic analysis, we conclude that the lungfish, and not the coelacanth, is the closest living relative of tetrapods. Coelacanth protein-coding genes are significantly more slowly evolving than those of tetrapods, unlike other genomic features. Analyses of changes in genes and regulatory elements during the vertebrate adaptation to land highlight genes involved in immunity, nitrogen excretion and the development of fins, tail, ear, eye, brain and olfaction. Functional assays of enhancers involved in the fin-to-limb transition and in the emergence of extra-embryonic tissues show the importance of the coelacanth genome as a blueprint for understanding tetrapod evolution.

601 citations

Journal ArticleDOI
TL;DR: A meta-analysis of genome-wide association study data of height from 15,821 individuals at 2.2 million SNPs found 10 newly identified and two previously reported loci were strongly associated with variation in height, and highlight several pathways as important regulators of human stature.
Abstract: Identification of ten loci associated with height highlights new biological pathways in human growth

598 citations

Journal ArticleDOI
TL;DR: The incidence of typhoid varied substantially between sites, being high in India and Pakistan, intermediate in Indonesia, and low in China and Viet Nam, and underscore the importance of evidence on disease burden in making policy decisions about interventions to control this disease.
Abstract: Objective To inform policy-makers about introduction of preventive interventions against typhoid, including vaccination. Methods A population-based prospective surveillance design was used. Study sites where typhoid was considered a problem by local authorities were established in China, India, Indonesia, Pakistan and Viet Nam. Standardized clinical, laboratory, and surveillance methods were used to investigate cases of fever of ³ 3 days’ duration for a one-year period. A total of 441 435 persons were under surveillance, 159 856 of whom were aged 5–15 years. Findings A total of 21 874 episodes of fever were detected. Salmonella typhi was isolated from 475 (2%) blood cultures, 57% (273/475) of which were from 5–15 year-olds. The annual typhoid incidence (per 100 000 person years) among this age group varied from 24.2 and 29.3 in sites in Viet Nam and China, respectively, to 180.3 in the site in Indonesia; and to 412.9 and 493.5 in sites in Pakistan and India, respectively. Altogether, 23% (96/413) of isolates were multidrug resistant (chloramphenicol, ampicillin and trimethoprim-sulfamethoxazole). Conclusion The incidence of typhoid varied substantially between sites, being high in India and Pakistan, intermediate in Indonesia, and low in China and Viet Nam. These findings highlight the considerable, but geographically heterogeneous, burden of typhoid fever in endemic areas of Asia, and underscore the importance of evidence on disease burden in making policy decisions about interventions to control this disease.

596 citations


Authors

Showing all 4058 results

NameH-indexPapersCitations
Nicholas J. Wareham2121657204896
Gonçalo R. Abecasis179595230323
Panos Deloukas162410154018
Michael R. Stratton161443142586
David W. Johnson1602714140778
Michael John Owen1601110135795
Naveed Sattar1551326116368
Robert E. W. Hancock15277588481
Julian Parkhill149759104736
Nilesh J. Samani149779113545
Michael Conlon O'Donovan142736118857
Jian Yang1421818111166
Christof Koch141712105221
Andrew G. Clark140823123333
Stylianos E. Antonarakis13874693605
Network Information
Related Institutions (5)
Broad Institute
11.6K papers, 1.5M citations

96% related

Howard Hughes Medical Institute
34.6K papers, 5.2M citations

95% related

Laboratory of Molecular Biology
24.2K papers, 2.1M citations

94% related

Salk Institute for Biological Studies
13.1K papers, 1.6M citations

93% related

National Institutes of Health
297.8K papers, 21.3M citations

93% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
202317
202270
2021836
2020810
2019854
2018764